Are NHS patients keeping up with European neighbours on access to new medicines?
NHS patients in England rank 7th in Europe for access to newly approved medicines, according to the latest EFPIA W.A.I.T. Indicator report — but significant gaps remain, particularly for cancer and rare disease treatments. With only 33% of medicines available on a fully unrestricted basis, and thousands of patients waiting for life-changing therapies, how do
ABPI Blogs and News4d ago 
